June S Peng

19PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisSystems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 16, 2026
Optimal Management of Clinical T2N0 Gastric Adenocarcinoma: Surgery or Chemotherapy First?

|Sep 27, 2024
Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC).

Han Yin, Fernanda Romero-Hernandez, Amir Ashraf Ganjouei

|Jul 22, 2024
Complete response to chemotherapy in a 6-year survivor of metastatic pancreatic cancer.

Cynthia E Burke, Nina L Eng, Nelson S Yee

|Apr 09, 2024
Total pancreatectomy, splenectomy and remnant gastrectomy for invasive intraductal papillary mucinous neoplasm (IPMN) after prior Roux-en-Y gastric bypass.

Joanna T Buchheit, Isha Joshi, Matthew E Dixon

|Dec 30, 2022
Metachronous metastatic pancreatoblastoma to the liver in an elderly patient misdiagnosed as pancreatic acinar cell carcinoma.

Nina L Eng, Kriti Tiwari, Guoli Chen

|Aug 30, 2022
Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment?

Rolfy A Perez Holguin, Elizabeth J Olecki, Kelly A Stahl

Pageof 4

Frequent Collaborators

4 joint publications

Elizabeth J Olecki

3 joint publications

Matthew E Dixon

1 joint publications

Moshim Kukar

1 joint publications

Kelly A Stahl